España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
BioLine Rx
BLRX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.2030
0.00100
0.50%
At close: -
$0.2084
0.00540
2.66%
After Hours: Dec 20, 6:31 PM EDT
Get Report
Comment
BioLine Rx (BLRX) Forecast
News
Earnings
BioLine Rx (BLRX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for BioLine Rx (NASDAQ:BLRX) Stock
BioLine Rx Stock (NASDAQ: BLRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 25, 2024
HC Wainwright & Co. Maintains Buy on BioLine ...
Benzinga Newsdesk
BioLine Rx Q3 2024 GAAP EPS $(0.00) Beats $(0...
Benzinga Newsdesk
Earnings Scheduled For November 25, 2024
Benzinga Insights
Friday, November 22, 2024
Earnings Preview For BioLine Rx
Benzinga Insights
Thursday, November 21, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
BioLineRx And Ayrmid Entered Into A License A...
Benzinga Newsdesk
Wednesday, November 06, 2024
HC Wainwright & Co. Reiterates Buy on BioLine...
Benzinga Newsdesk
Tuesday, November 05, 2024
BioLineRx Announces Oral Presentation On Data...
Benzinga Newsdesk
Wednesday, October 16, 2024
BioLineRx Announces USPTO Allowance Of New Co...
Benzinga Newsdesk
Friday, October 11, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Monday, October 07, 2024
Why Arcadium Lithium Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, September 17, 2024
BioLineRx Launches 'Mobilization Matters', A ...
Benzinga Newsdesk
Wednesday, September 04, 2024
Jones Trading Initiates Coverage On BioLine R...
Benzinga Newsdesk
Thursday, August 15, 2024
BioLineRx shares are trading lower. The compa...
Benzinga Newsdesk
As Of June 30, 2024, BioLineRx Had Cash, Cash...
Benzinga Newsdesk
BioLine Rx Q2 2024 GAAP EPS $0.00 Beats $(0.1...
Benzinga Newsdesk
Monday, June 03, 2024
HC Wainwright & Co. Reiterates Buy on BioLine...
Benzinga Newsdesk
Thursday, May 30, 2024
BioLineRx Announces Multi-Center Phase 1 Tria...
Benzinga Newsdesk
Wednesday, May 29, 2024
HC Wainwright & Co. Reiterates Buy on BioLine...
Benzinga Newsdesk
Tuesday, May 28, 2024
BioLineRx shares are trading higher. The comp...
Benzinga Newsdesk
BioLineRx Says Cash, Cash Equivalents, And Sh...
Benzinga Newsdesk
BioLine Rx Q1 2024 GAAP EPS $(0.00) May Not B...
Benzinga Newsdesk
Friday, May 24, 2024
BioLineRx Discloses Abstract On Pilot Study D...
Benzinga Newsdesk
Monday, May 06, 2024
BioLineRx To Present Poster On Economic Model...
Benzinga Newsdesk
Wednesday, April 17, 2024
HC Wainwright & Co. Reiterates Buy on BioLine...
Benzinga Newsdesk
BioLineRx Announces Poster Presentation On Ap...
Benzinga Newsdesk
Wednesday, April 10, 2024
BioLineRx Has Drawn-down The Second Tranche O...
Benzinga Newsdesk
Monday, April 01, 2024
BioLineRx shares are trading lower after the ...
Benzinga Newsdesk
BioLineRx Announces $6M Registered Direct Off...
Benzinga Newsdesk
Tuesday, March 26, 2024
HC Wainwright & Co. Reiterates Buy on BioLine...
Benzinga Newsdesk
BioLine Rx Q4 EPS $(0.15) Beats $(0.22) Estimate, Sales $4.80M
Happy Mohamed
BioLineRx shares are trading lower after the ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
BioLineRx FY23 Total Revenues $4.8M, EPS $(0....
Benzinga Newsdesk
Earnings Scheduled For March 26, 2024
Benzinga Insights
Monday, March 25, 2024
Earnings Preview For BioLine Rx
Benzinga Insights
Monday, March 04, 2024
BioLineRx Announces Notice of Allowance for U...
Benzinga Newsdesk
Thursday, February 29, 2024
HC Wainwright & Co. Reiterates Buy on BioLine...
Benzinga Newsdesk
Wednesday, February 28, 2024
Biolinerx Announced First Patient Dosed In Ra...
Charles Gross
Friday, February 16, 2024
BioLineRx Discloses Acceptance Of Two Poster ...
Benzinga Newsdesk
Thursday, December 21, 2023
BioLineRx Says First Patient Has Been Dosed I...
Benzinga Newsdesk
Monday, November 20, 2023
HC Wainwright & Co. Reiterates Buy on BioLine...
Benzinga Newsdesk
Earnings Scheduled For November 20, 2023
Benzinga Insights
BioLine Rx Says Cash, Cash Equivalents And Sh...
Benzinga Newsdesk
BioLine Rx Q3 EPS $(0.01) May Not Be Comparab...
Benzinga Newsdesk
Friday, November 17, 2023
BioLine Rx Earnings Preview
Benzinga Insights
Tuesday, October 31, 2023
CORRECTION: BlueLinx Ticker Is "BXC"
Benzinga Newsdesk
BioLineRx shares are trading higher after the...
Benzinga Newsdesk
BioLineRx Entered Exclusive License Agreement...
Benzinga Newsdesk
Thursday, October 12, 2023
BioLineRx Announces Closing of Exclusive Lice...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch